302 related articles for article (PubMed ID: 25345095)
1. Mucopolysaccharidosis III (Sanfilippo Syndrome)- disease presentation and experimental therapies.
Gilkes JA; Heldermon CD
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():133-40. PubMed ID: 25345095
[TBL] [Abstract][Full Text] [Related]
2. Glycosaminoglycans and mucopolysaccharidosis type III.
Jakobkiewicz-Banecka J; Gabig-Ciminska M; Kloska A; Malinowska M; Piotrowska E; Banecka-Majkutewicz Z; Banecki B; Wegrzyn A; Wegrzyn G
Front Biosci (Landmark Ed); 2016 Jun; 21(7):1393-409. PubMed ID: 27100513
[TBL] [Abstract][Full Text] [Related]
3. How close are we to therapies for Sanfilippo disease?
Gaffke L; Pierzynowska K; Piotrowska E; Węgrzyn G
Metab Brain Dis; 2018 Feb; 33(1):1-10. PubMed ID: 28921412
[TBL] [Abstract][Full Text] [Related]
4. Mucopolysaccharidosis type III (Sanfilippo Syndrome): emerging treatment strategies.
de Ruijter J; Valstar MJ; Wijburg FA
Curr Pharm Biotechnol; 2011 Jun; 12(6):923-30. PubMed ID: 21235449
[TBL] [Abstract][Full Text] [Related]
5. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)].
Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT
Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774
[TBL] [Abstract][Full Text] [Related]
6. Sanfilippo syndrome: Overall review.
Andrade F; Aldámiz-Echevarría L; Llarena M; Couce ML
Pediatr Int; 2015 Jun; 57(3):331-8. PubMed ID: 25851924
[TBL] [Abstract][Full Text] [Related]
7. Novel therapies for mucopolysaccharidosis type III.
Seker Yilmaz B; Davison J; Jones SA; Baruteau J
J Inherit Metab Dis; 2021 Jan; 44(1):129-147. PubMed ID: 32944950
[TBL] [Abstract][Full Text] [Related]
8. Update of the spectrum of mucopolysaccharidoses type III in Tunisia: identification of three novel mutations and in silico structural analysis of the missense mutations.
Ouesleti S; Coutinho MF; Ribeiro I; Miled A; Mosbahi DS; Alves S
World J Pediatr; 2017 Aug; 13(4):374-380. PubMed ID: 28101780
[TBL] [Abstract][Full Text] [Related]
9. Update of treatment for mucopolysaccharidosis type III (sanfilippo syndrome).
Kong W; Yao Y; Zhang J; Lu C; Ding Y; Meng Y
Eur J Pharmacol; 2020 Dec; 888():173562. PubMed ID: 32949598
[TBL] [Abstract][Full Text] [Related]
10. Sanfilippo syndrome type C: mutation spectrum in the heparan sulfate acetyl-CoA: alpha-glucosaminide N-acetyltransferase (HGSNAT) gene.
Feldhammer M; Durand S; Mrázová L; Boucher RM; Laframboise R; Steinfeld R; Wraith JE; Michelakakis H; van Diggelen OP; Hrebícek M; Kmoch S; Pshezhetsky AV
Hum Mutat; 2009 Jun; 30(6):918-25. PubMed ID: 19479962
[TBL] [Abstract][Full Text] [Related]
11. Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α-
Wang F; Moen DR; Sauni C; Kan SH; Li S; Le SQ; Lomenick B; Zhang X; Ekins S; Singamsetty S; Wood J; Dickson PI; Chou TF
Mol Pharm; 2021 Jan; 18(1):214-227. PubMed ID: 33320673
[TBL] [Abstract][Full Text] [Related]
12. BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis.
Yogalingam G; Luu AR; Prill H; Lo MJ; Yip B; Holtzinger J; Christianson T; Aoyagi-Scharber M; Lawrence R; Crawford BE; LeBowitz JH
PLoS One; 2019; 14(1):e0207836. PubMed ID: 30657762
[TBL] [Abstract][Full Text] [Related]
13. Drosophila melanogaster models of MPS IIIC (Hgsnat-deficiency) highlight the role of glia in disease presentation.
Hewson L; Choo A; Webber DL; Trim PJ; Snel MF; Fedele AO; Hopwood JJ; Hemsley KM; O'Keefe LV
J Inherit Metab Dis; 2024 Mar; 47(2):340-354. PubMed ID: 38238109
[TBL] [Abstract][Full Text] [Related]
14. Sanfilippo syndrome: a mini-review.
Valstar MJ; Ruijter GJ; van Diggelen OP; Poorthuis BJ; Wijburg FA
J Inherit Metab Dis; 2008 Apr; 31(2):240-52. PubMed ID: 18392742
[TBL] [Abstract][Full Text] [Related]
15. Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome.
Kan SH; Elsharkawi I; Le SQ; Prill H; Mangini L; Cooper JD; Lawrence R; Sands MS; Crawford BE; Dickson PI
Mol Genet Metab; 2021 Jun; 133(2):185-192. PubMed ID: 33839004
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of MPS IIIA, MPS IIIB and MPS IIIC in Tunisian patients.
Ouesleti S; Brunel V; Ben Turkia H; Dranguet H; Miled A; Miladi N; Ben Dridi MF; Lavoinne A; Saugier-Veber P; Bekri S
Clin Chim Acta; 2011 Nov; 412(23-24):2326-31. PubMed ID: 21910976
[TBL] [Abstract][Full Text] [Related]
17. Combined Hurler and Sanfilippo syndrome in a sibling pair.
Sun A; Hopwood JJ; Thompson J; Cederbaum SD
Mol Genet Metab; 2011 Jun; 103(2):135-7. PubMed ID: 21393040
[TBL] [Abstract][Full Text] [Related]
18. Therapy for mucopolysaccharidosis VI: (Maroteaux-Lamy syndrome) present status and prospects.
Giugliani R; Herber S; Lapagesse L; de Pinto C; Baldo G
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():152-8. PubMed ID: 25345097
[TBL] [Abstract][Full Text] [Related]
19. Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches.
Benetó N; Vilageliu L; Grinberg D; Canals I
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105639
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
